 SALT LAKE CITY, June 09, 2022 GLOBE NEWSWIRE -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc., NASDAQ: MYGN, a leader in genetic testing and precision medicine, will discuss the companys transformation and growth plan during a fireside chat at the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022 at 4:20 p.m. EDT. 